Healio

Navenibart safe, lowers hereditary angioedema attack rate up to 24 months

Among adults with hereditary angioedema, the safety of navenibart up to 24 months was favorable, according to interim trial ...
EurekAlert!

New factor implicated in allergy and asthma attacks

GALVESTON, Texas--For a person with allergies or asthma, breathing in pollen can be a very bad thing. Within minutes of inhalation by someone sensitive to their effects, these tiny particles can ...

KalVista Pharmaceuticals Presents New Data Highlighting High Patient Satisfaction and Evolving Treatment Trends with EKTERLY® (sebetralstat)

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new data from its sebetralstat clinical trial program presented ...
ABC7 San Francisco

Study shows U.S. schools unprepared for student asthma, allergy attacks

SAN FRANCISCO (KGO) -- A new study has released some disturbing findings about how unprepared the nation's schools are when it comes to dealing with childhood asthma or allergy attacks. Only one in ...
Medscape

Fix Mold, Reduce Asthma ED Visits?

New York City’s Mold Busters program is associated with thousands fewer emergency department visits for asthma per year, ...
Healio

Age, corticosteroid use impact asthma attack risk in women using progesterone-only pill

Please provide your email address to receive an email when new articles are posted on . Combined oral contraceptive use was not linked to asthma attacks. The link between progestogen-only pill use and ...

Understanding Pollen And Pollen Counts

Most pollen that causes allergy problems is so small that it is invisible to the human eye. Learn all about pollen, the ...

KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of three abstracts for presentation at the 2026 ...